Efficacy of Botulinum Toxin In Scleroderma-Associated Raynaud's Syndrome
Clinical trial NCT02165111 · COMPLETED
Trial details
- NCT number
- NCT02165111
- Sponsor
- Johns Hopkins University
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2015-09-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.